• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测日本 COVID-19 患者的呼吸衰竭:一种简单的临床评分,用于评估住院需求。

Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.

机构信息

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.

出版信息

Epidemiol Infect. 2021 Jul 30;149:e175. doi: 10.1017/S0950268821001837.

DOI:10.1017/S0950268821001837
PMID:36043382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8365048/
Abstract

Predicting the need for hospitalisation of patients with coronavirus disease 2019 (COVID-19) is important for preventing healthcare disruptions. This observational study aimed to use the COVID-19 Registry Japan (COVIREGI-JP) to develop a simple scoring system to predict respiratory failure due to COVID-19 using only underlying diseases and symptoms. A total of 6873 patients with COVID-19 admitted to Japanese medical institutions between 1 June 2020 and 2 December 2020 were included and divided into derivation and validation cohorts according to the date of admission. We used multivariable logistic regression analysis to create a simple risk score model, with respiratory failure as the outcome for young (18-39 years), middle-aged (40-64 years) and older (≥65 years) groups, using sex, age, body mass index, medical history and symptoms. The models selected for each age group were quite different. Areas under the receiver operating characteristic curves for the simple risk score model were 0.87, 0.79 and 0.80 for young, middle-aged and elderly derivation cohorts, and 0.81, 0.80 and 0.67 in the validation cohorts. Calibration of the model was good. The simple scoring system may be useful in the appropriate allocation of medical resources during the COVID-19 pandemic.

摘要

预测 2019 冠状病毒病(COVID-19)患者住院的需求对于防止医疗保健中断非常重要。本观察性研究旨在使用 COVID-19 注册日本(COVIREGI-JP),仅使用基础疾病和症状,开发一种预测 COVID-19 导致呼吸衰竭的简单评分系统。共纳入 2020 年 6 月 1 日至 2020 年 12 月 2 日期间在日本医疗机构住院的 6873 例 COVID-19 患者,并根据入院日期分为推导队列和验证队列。我们使用多变量逻辑回归分析,使用呼吸衰竭作为年轻(18-39 岁)、中年(40-64 岁)和老年(≥65 岁)组的结局,创建一个简单的风险评分模型,使用性别、年龄、体重指数、病史和症状。为每个年龄组选择的模型有很大的不同。简单风险评分模型在推导队列中的年轻、中年和老年组的受试者工作特征曲线下面积分别为 0.87、0.79 和 0.80,在验证队列中分别为 0.81、0.80 和 0.67。该模型的校准良好。简单评分系统可能有助于在 COVID-19 大流行期间合理分配医疗资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/fb27bbe6d813/S0950268821001837_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/4d44a308e5bc/S0950268821001837_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/44690568951b/S0950268821001837_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/29b1ada23d83/S0950268821001837_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/fb27bbe6d813/S0950268821001837_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/4d44a308e5bc/S0950268821001837_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/44690568951b/S0950268821001837_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/29b1ada23d83/S0950268821001837_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/8365048/fb27bbe6d813/S0950268821001837_fig4.jpg

相似文献

1
Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.预测日本 COVID-19 患者的呼吸衰竭:一种简单的临床评分,用于评估住院需求。
Epidemiol Infect. 2021 Jul 30;149:e175. doi: 10.1017/S0950268821001837.
2
An Easy-to-Use Machine Learning Model to Predict the Prognosis of Patients With COVID-19: Retrospective Cohort Study.一种用于预测COVID-19患者预后的易于使用的机器学习模型:回顾性队列研究
J Med Internet Res. 2020 Nov 9;22(11):e24225. doi: 10.2196/24225.
3
Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.开发和验证一种用于急诊科诊断 COVID-19 的简单风险评分。
Epidemiol Infect. 2020 Nov 13;148:e273. doi: 10.1017/S0950268820002769.
4
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem.对于确诊 2019 冠状病毒病住院患者,入院时预测呼吸衰竭的评分:一个复杂问题的简单工具。
Intern Emerg Med. 2022 Mar;17(2):515-524. doi: 10.1007/s11739-021-02748-2. Epub 2021 Apr 29.
5
Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19).肥胖、葡萄糖耐量异常、高龄和淋巴细胞减少是日本 2019 冠状病毒病(COVID-19)患者需要吸氧的独立危险因素。
Endocr J. 2021 Jul 28;68(7):849-856. doi: 10.1507/endocrj.EJ20-0784. Epub 2021 Mar 24.
6
A Practical Clinical Score Predicting Respiratory Failure in COVID-19 Patients.一种预测 COVID-19 患者呼吸衰竭的实用临床评分。
Isr Med Assoc J. 2022 May;24(5):327-331.
7
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan.在日本的一项大型 COVID-19 患者队列中,入院时严重程度和住院期间疾病进展的危险因素。
BMJ Open. 2021 Jun 15;11(6):e047007. doi: 10.1136/bmjopen-2020-047007.
8
Development and Validation of a Clinical Score to Predict Neurological Outcomes in Patients With Out-of-Hospital Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation.《应用体外心肺复苏治疗院外心脏骤停患者的临床评分对预测其神经系统结局的开发与验证》
JAMA Netw Open. 2020 Nov 2;3(11):e2022920. doi: 10.1001/jamanetworkopen.2020.22920.
9
Development and external validation of a COVID-19 mortality risk prediction algorithm: a multicentre retrospective cohort study.开发和验证 COVID-19 死亡率预测算法的多中心回顾性队列研究。
BMJ Open. 2020 Dec 24;10(12):e044028. doi: 10.1136/bmjopen-2020-044028.
10
Construction and validation of a machine learning-based nomogram: A tool to predict the risk of getting severe coronavirus disease 2019 (COVID-19).基于机器学习的列线图的构建与验证:预测 2019 年冠状病毒病(COVID-19)重症风险的工具。
Immun Inflamm Dis. 2021 Jun;9(2):595-607. doi: 10.1002/iid3.421. Epub 2021 Mar 13.

引用本文的文献

1
Vital Signs as Predictors of Oxygen Requirements in COVID-19 Outpatients: The Development of a Streamlined Risk Score.生命体征作为新冠门诊患者氧气需求的预测指标:简化风险评分的制定
Cureus. 2024 May 28;16(5):e61270. doi: 10.7759/cureus.61270. eCollection 2024 May.
2
Descriptive epidemiology of COVID-19 in Japan 2020: insights from a multihospital database.2020年日本新型冠状病毒肺炎的描述性流行病学:来自多医院数据库的见解
Ann Clin Epidemiol. 2022 Sep 29;5(1):5-12. doi: 10.37737/ace.23002. eCollection 2023.
3
Use of a rapid triage assessment tool to discriminate the need for hospitalisation in patients with severe COVID-19 infection presenting to an outpatient clinic: a single-centre, prospective cohort study.

本文引用的文献

1
Silent hypoxaemia in COVID-19 patients.新型冠状病毒肺炎患者的静默性低氧血症。
J Physiol. 2021 Feb;599(4):1057-1065. doi: 10.1113/JP280769. Epub 2021 Jan 4.
2
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review.新冠病毒病中既往存在的肝脏疾病及入院时肝脏相关实验室检查:一项系统评价的预后准确性Meta分析
Front Med (Lausanne). 2020 Nov 13;7:572115. doi: 10.3389/fmed.2020.572115. eCollection 2020.
3
Risk factors for severe and critically ill COVID-19 patients: A review.
使用快速分诊评估工具来区分因严重 COVID-19 感染而到门诊就诊的患者是否需要住院治疗:一项单中心前瞻性队列研究。
BMJ Open. 2023 Nov 29;13(11):e073781. doi: 10.1136/bmjopen-2023-073781.
4
Risk Factors for Bleeding in Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation and Effects of Transcatheter Arterial Embolization for Hemostasis.2019冠状病毒病患者接受体外膜肺氧合治疗时出血的危险因素及经导管动脉栓塞术止血的效果
Interv Radiol (Higashimatsuyama). 2023 Sep 21;8(3):136-145. doi: 10.22575/interventionalradiology.2022-0043. eCollection 2023 Nov 1.
5
High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case-Control Study.高热、广泛分布的病毒性肺炎及胸腔积液是初诊时预测新型冠状病毒肺炎预后的更关键发现:一项单中心、回顾性、倾向评分匹配病例对照研究
Int J Gen Med. 2023 Jun 8;16:2337-2348. doi: 10.2147/IJGM.S408907. eCollection 2023.
6
Association between vaccination status and severe health consequences among community-dwelling COVID-19 patients during Omicron BA.1/BA.2 and BA.5-predominant periods in Japan.在日本奥密克戎 BA.1/BA.2 和 BA.5 为主导时期,社区居民 COVID-19 患者中疫苗接种状况与严重健康后果之间的关联。
Environ Health Prev Med. 2023;28:35. doi: 10.1265/ehpm.23-00061.
7
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction.考虑到预测临床需求的时间,验证血清 IL-6、IFN-λ3、CCL17 和钙卫蛋白对严重 COVID-19 的预后价值。
PLoS One. 2023 Mar 30;18(3):e0279897. doi: 10.1371/journal.pone.0279897. eCollection 2023.
8
Association between vaccination status and COVID-19-related health outcomes among community-dwelling COVID-19 patients in Nara, Japan.在日本奈良,社区居民中 COVID-19 患者的疫苗接种状况与 COVID-19 相关健康结果之间的关联。
Environ Health Prev Med. 2023;28:7. doi: 10.1265/ehpm.22-00199.
9
Evaluation of the representativeness of data in the COVID-19 Registry Japan during the first six waves of the epidemic.评估日本COVID-19登记处在疫情前六波期间数据的代表性。
Glob Health Med. 2022 Aug 31;4(4):204-209. doi: 10.35772/ghm.2022.01033.
10
Methylprednisolone pulse therapy for critically ill patients with coronavirus disease 2019: A single-center retrospective observational study.甲泼尼龙冲击疗法用于2019冠状病毒病危重症患者:一项单中心回顾性观察研究。
Acute Med Surg. 2022 Sep 6;9(1):e782. doi: 10.1002/ams2.782. eCollection 2022 Jan-Dec.
COVID-19 患者重症和危重症的危险因素:综述。
Allergy. 2021 Feb;76(2):428-455. doi: 10.1111/all.14657. Epub 2020 Dec 4.
4
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics.日本的第一波和第二波新冠疫情:疾病严重程度和特征的比较。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.10.033. Epub 2020 Nov 2.
5
Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions.预测 COVID-19 院内死亡率的因素:一项全面的系统综述和荟萃分析,探讨了年龄、性别和健康状况的差异。
PLoS One. 2020 Nov 3;15(11):e0241742. doi: 10.1371/journal.pone.0241742. eCollection 2020.
6
Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms.仅使用患者人口统计学、合并症和症状预测与 Covid-19 相关疾病的严重结局。
Am J Emerg Med. 2021 Jul;45:378-384. doi: 10.1016/j.ajem.2020.09.017. Epub 2020 Sep 9.
7
Asthma-associated risk for COVID-19 development.哮喘与 COVID-19 发展的相关性风险。
J Allergy Clin Immunol. 2020 Dec;146(6):1295-1301. doi: 10.1016/j.jaci.2020.09.017. Epub 2020 Sep 28.
8
Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan.日本 2019 年冠状病毒病(COVID-19)住院患者的临床流行病学:COVID-19 登记日本报告。
Clin Infect Dis. 2021 Dec 6;73(11):e3677-e3689. doi: 10.1093/cid/ciaa1470.
9
Effect of obesity and body mass index on coronavirus disease 2019 severity: A systematic review and meta-analysis.肥胖和体重指数对 2019 年冠状病毒病严重程度的影响:系统评价和荟萃分析。
Obes Rev. 2020 Nov;21(11):e13089. doi: 10.1111/obr.13089. Epub 2020 Sep 14.
10
Retooling Primary Care in the COVID-19 Era.重塑新冠疫情时代的初级医疗保健服务
Mayo Clin Proc. 2020 Sep;95(9):1831-1834. doi: 10.1016/j.mayocp.2020.06.050. Epub 2020 Jul 23.